| UniProt ID | PUS7_HUMAN | |
|---|---|---|
| UniProt AC | Q96PZ0 | |
| Protein Name | Pseudouridylate synthase 7 homolog {ECO:0000305} | |
| Gene Name | PUS7 {ECO:0000312|HGNC:HGNC:26033} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 661 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Pseudouridylate synthase that catalyzes pseudouridylation of RNAs. [PubMed: 28073919] | |
| Protein Sequence | MEMTEMTGVSLKRGALVVEDNDSGVPVEETKKQKLSECSLTKGQDGLQNDFLSISEDVPRPPDTVSTGKGGKNSEAQLEDEEEEEEDGLSEECEEEESESFADMMKHGLTEADVGITKFVSSHQGFSGILKERYSDFVVHEIGKDGRISHLNDLSIPVDEEDPSEDIFTVLTAEEKQRLEELQLFKNKETSVAIEVIEDTKEKRTIIHQAIKSLFPGLETKTEDREGKKYIVAYHAAGKKALANPRKHSWPKSRGSYCHFVLYKENKDTMDAINVLSKYLRVKPNIFSYMGTKDKRAITVQEIAVLKITAQRLAHLNKCLMNFKLGNFSYQKNPLKLGELQGNHFTVVLRNITGTDDQVQQAMNSLKEIGFINYYGMQRFGTTAVPTYQVGRAILQNSWTEVMDLILKPRSGAEKGYLVKCREEWAKTKDPTAALRKLPVKRCVEGQLLRGLSKYGMKNIVSAFGIIPRNNRLMYIHSYQSYVWNNMVSKRIEDYGLKPVPGDLVLKGATATYIEEDDVNNYSIHDVVMPLPGFDVIYPKHKIQEAYREMLTADNLDIDNMRHKIRDYSLSGAYRKIIIRPQNVSWEVVAYDDPKIPLFNTDVDNLEGKTPPVFASEGKYRALKMDFSLPPSTYATMAIREVLKMDTSIKNQTQLNTTWLR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEMTEMTG -------CCCCCCCC | 7.78 | 22814378 | |
| 4 | O-linked_Glycosylation | ----MEMTEMTGVSL ----CCCCCCCCEEE | 14.86 | 30379171 | |
| 10 | Phosphorylation | MTEMTGVSLKRGALV CCCCCCEEEECCEEE | 29.53 | 24114839 | |
| 13 | Methylation | MTGVSLKRGALVVED CCCEEEECCEEEEEE | 40.69 | 115489675 | |
| 23 | Phosphorylation | LVVEDNDSGVPVEET EEEEECCCCCCCHHH | 48.20 | 25159151 | |
| 31 | Acetylation | GVPVEETKKQKLSEC CCCCHHHHHCCHHHC | 57.39 | 26051181 | |
| 36 | Phosphorylation | ETKKQKLSECSLTKG HHHHCCHHHCCCCCC | 43.52 | 20873877 | |
| 39 | Phosphorylation | KQKLSECSLTKGQDG HCCHHHCCCCCCCCC | 34.71 | 21815630 | |
| 41 | Phosphorylation | KLSECSLTKGQDGLQ CHHHCCCCCCCCCCC | 19.48 | 25850435 | |
| 53 | Phosphorylation | GLQNDFLSISEDVPR CCCCCCCCCCCCCCC | 24.86 | 27251275 | |
| 55 | Phosphorylation | QNDFLSISEDVPRPP CCCCCCCCCCCCCCC | 25.11 | 28348404 | |
| 64 | Phosphorylation | DVPRPPDTVSTGKGG CCCCCCCCCCCCCCC | 23.33 | 25159151 | |
| 66 | Phosphorylation | PRPPDTVSTGKGGKN CCCCCCCCCCCCCCC | 33.27 | 30576142 | |
| 67 | Phosphorylation | RPPDTVSTGKGGKNS CCCCCCCCCCCCCCC | 38.28 | 27732954 | |
| 69 | Acetylation | PDTVSTGKGGKNSEA CCCCCCCCCCCCCCC | 65.66 | 25953088 | |
| 74 | Phosphorylation | TGKGGKNSEAQLEDE CCCCCCCCCCCCCCH | 37.48 | 30576142 | |
| 90 | Phosphorylation | EEEEDGLSEECEEEE HHHHCCCCHHHHHHH | 36.56 | 27422710 | |
| 98 | Phosphorylation | EECEEEESESFADMM HHHHHHHHHHHHHHH | 41.65 | 22210691 | |
| 100 | Phosphorylation | CEEEESESFADMMKH HHHHHHHHHHHHHHC | 34.71 | 22210691 | |
| 118 | Acetylation | EADVGITKFVSSHQG HHHHCHHHHHHCCCC | 41.68 | 26051181 | |
| 121 | Phosphorylation | VGITKFVSSHQGFSG HCHHHHHHCCCCCCH | 25.82 | 25159151 | |
| 122 | Phosphorylation | GITKFVSSHQGFSGI CHHHHHHCCCCCCHH | 17.96 | 25627689 | |
| 127 | Phosphorylation | VSSHQGFSGILKERY HHCCCCCCHHHHHHH | 31.58 | 25159151 | |
| 131 | Acetylation | QGFSGILKERYSDFV CCCCHHHHHHHCCEE | 37.92 | 19608861 | |
| 134 | Phosphorylation | SGILKERYSDFVVHE CHHHHHHHCCEEEEE | 17.43 | 29214152 | |
| 135 | Phosphorylation | GILKERYSDFVVHEI HHHHHHHCCEEEEEC | 30.69 | 28555341 | |
| 144 | Ubiquitination | FVVHEIGKDGRISHL EEEEECCCCCCCEEC | 63.77 | - | |
| 144 | Acetylation | FVVHEIGKDGRISHL EEEEECCCCCCCEEC | 63.77 | 25953088 | |
| 155 | Phosphorylation | ISHLNDLSIPVDEED CEECCCCCCCCCCCC | 27.92 | 25159151 | |
| 176 | Ubiquitination | TVLTAEEKQRLEELQ EEEEHHHHHHHHHHH | 32.02 | 21890473 | |
| 190 | Phosphorylation | QLFKNKETSVAIEVI HHHCCCCCCEEEEEE | 30.06 | 26074081 | |
| 191 | Phosphorylation | LFKNKETSVAIEVIE HHCCCCCCEEEEEEC | 15.61 | 26074081 | |
| 200 | Phosphorylation | AIEVIEDTKEKRTII EEEEECCCCHHHHHH | 28.45 | 26074081 | |
| 213 | Phosphorylation | IIHQAIKSLFPGLET HHHHHHHHHCCCCCC | 29.18 | 21406692 | |
| 220 | Phosphorylation | SLFPGLETKTEDREG HHCCCCCCCCCCCCC | 48.59 | 21406692 | |
| 221 | Ubiquitination | LFPGLETKTEDREGK HCCCCCCCCCCCCCC | 40.31 | - | |
| 230 | Phosphorylation | EDREGKKYIVAYHAA CCCCCCEEEEEEECC | 12.24 | 20068231 | |
| 234 | Phosphorylation | GKKYIVAYHAAGKKA CCEEEEEEECCCHHH | 4.90 | 20068231 | |
| 239 | Acetylation | VAYHAAGKKALANPR EEEECCCHHHHCCCC | 30.10 | 26051181 | |
| 249 | Phosphorylation | LANPRKHSWPKSRGS HCCCCCCCCCCCCCC | 48.38 | 26091039 | |
| 254 | Methylation | KHSWPKSRGSYCHFV CCCCCCCCCCEEEEE | 44.17 | 115489683 | |
| 263 | Phosphorylation | SYCHFVLYKENKDTM CEEEEEEEECCCCHH | 15.79 | 22817900 | |
| 269 | Phosphorylation | LYKENKDTMDAINVL EEECCCCHHHHHHHH | 20.68 | 29116813 | |
| 270 | Sulfoxidation | YKENKDTMDAINVLS EECCCCHHHHHHHHH | 4.74 | 21406390 | |
| 277 | Phosphorylation | MDAINVLSKYLRVKP HHHHHHHHHHHCCCC | 18.25 | 29116813 | |
| 278 | Ubiquitination | DAINVLSKYLRVKPN HHHHHHHHHHCCCCC | 44.11 | 21906983 | |
| 279 | Phosphorylation | AINVLSKYLRVKPNI HHHHHHHHHCCCCCC | 9.07 | 29116813 | |
| 292 | Phosphorylation | NIFSYMGTKDKRAIT CCHHHCCCCCCCCEE | 21.38 | 29116813 | |
| 318 | Acetylation | QRLAHLNKCLMNFKL HHHHHHHHHHHHCCC | 34.80 | 25953088 | |
| 318 | Ubiquitination | QRLAHLNKCLMNFKL HHHHHHHHHHHHCCC | 34.80 | 21906983 | |
| 324 | Ubiquitination | NKCLMNFKLGNFSYQ HHHHHHCCCCCCCCC | 50.94 | 21906983 | |
| 332 | Ubiquitination | LGNFSYQKNPLKLGE CCCCCCCCCCCCCCC | 52.91 | - | |
| 353 | Phosphorylation | TVVLRNITGTDDQVQ EEEEEECCCCHHHHH | 37.26 | 21406692 | |
| 355 | Phosphorylation | VLRNITGTDDQVQQA EEEECCCCHHHHHHH | 27.96 | 21406692 | |
| 365 | Phosphorylation | QVQQAMNSLKEIGFI HHHHHHHHHHHHCCE | 27.94 | 21406692 | |
| 403 | Sulfoxidation | QNSWTEVMDLILKPR HCCHHHHHHHHHCCC | 2.56 | 28183972 | |
| 411 | Phosphorylation | DLILKPRSGAEKGYL HHHHCCCCCCCCCEE | 51.38 | 22210691 | |
| 415 | Ubiquitination | KPRSGAEKGYLVKCR CCCCCCCCCEEEEEH | 52.93 | - | |
| 420 | Ubiquitination | AEKGYLVKCREEWAK CCCCEEEEEHHHHHH | 25.61 | - | |
| 450 | Methylation | CVEGQLLRGLSKYGM HHHHHHHHHHHHHCC | 53.23 | 30988967 | |
| 455 | Phosphorylation | LLRGLSKYGMKNIVS HHHHHHHHCCCHHHH | 21.05 | 23532336 | |
| 462 | Phosphorylation | YGMKNIVSAFGIIPR HCCCHHHHHHCEECC | 17.68 | 22199227 | |
| 475 | Phosphorylation | PRNNRLMYIHSYQSY CCCCEEEEEEEEHHH | 10.48 | - | |
| 479 | Phosphorylation | RLMYIHSYQSYVWNN EEEEEEEEHHHHHHH | 6.31 | - | |
| 482 | Phosphorylation | YIHSYQSYVWNNMVS EEEEEHHHHHHHHHC | 8.24 | - | |
| 495 | Phosphorylation | VSKRIEDYGLKPVPG HCHHHHHCCCCCCCC | 16.15 | - | |
| 542 | Ubiquitination | DVIYPKHKIQEAYRE CEEECHHHHHHHHHH | 52.81 | - | |
| 550 | Sulfoxidation | IQEAYREMLTADNLD HHHHHHHHHHCCCCC | 2.74 | 21406390 | |
| 568 | Phosphorylation | MRHKIRDYSLSGAYR HHHHHHHCCCCCCEE | 11.15 | 20068231 | |
| 569 | Phosphorylation | RHKIRDYSLSGAYRK HHHHHHCCCCCCEEE | 21.98 | 20068231 | |
| 571 | Phosphorylation | KIRDYSLSGAYRKII HHHHCCCCCCEEEEE | 18.55 | 20068231 | |
| 574 | Phosphorylation | DYSLSGAYRKIIIRP HCCCCCCEEEEEECC | 18.90 | 20068231 | |
| 585 | Phosphorylation | IIRPQNVSWEVVAYD EECCCCEEEEEEEEC | 25.68 | 22210691 | |
| 601 | Phosphorylation | PKIPLFNTDVDNLEG CCCCCCCCCCHHCCC | 30.02 | 28176443 | |
| 609 | Sumoylation | DVDNLEGKTPPVFAS CCHHCCCCCCCCCCC | 48.78 | - | |
| 609 | Ubiquitination | DVDNLEGKTPPVFAS CCHHCCCCCCCCCCC | 48.78 | - | |
| 610 | Phosphorylation | VDNLEGKTPPVFASE CHHCCCCCCCCCCCC | 43.62 | 29255136 | |
| 616 | Phosphorylation | KTPPVFASEGKYRAL CCCCCCCCCCCEEEE | 35.10 | 28176443 | |
| 619 | Sumoylation | PVFASEGKYRALKMD CCCCCCCCEEEEECC | 27.75 | - | |
| 619 | Sumoylation | PVFASEGKYRALKMD CCCCCCCCEEEEECC | 27.75 | - | |
| 619 | Ubiquitination | PVFASEGKYRALKMD CCCCCCCCEEEEECC | 27.75 | - | |
| 619 | Acetylation | PVFASEGKYRALKMD CCCCCCCCEEEEECC | 27.75 | 23954790 | |
| 628 | Phosphorylation | RALKMDFSLPPSTYA EEEECCCCCCHHHHH | 35.38 | - | |
| 648 | Phosphorylation | EVLKMDTSIKNQTQL HHHCCCCCCCCCCCC | 27.57 | 25003641 | |
| 657 | Phosphorylation | KNQTQLNTTWLR--- CCCCCCCCCCCC--- | 28.13 | 23186163 | |
| 658 | Phosphorylation | NQTQLNTTWLR---- CCCCCCCCCCC---- | 22.79 | 25159151 | |
| 661 | Methylation | QLNTTWLR------- CCCCCCCC------- | 35.73 | 115489667 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PUS7_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PUS7_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PUS7_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| WDR74_HUMAN | WDR74 | physical | 22939629 | |
| HS105_HUMAN | HSPH1 | physical | 22863883 | |
| STAT3_HUMAN | STAT3 | physical | 22863883 | |
| ACO13_HUMAN | ACOT13 | physical | 26344197 | |
| ACTN4_HUMAN | ACTN4 | physical | 26344197 | |
| BYST_HUMAN | BYSL | physical | 26344197 | |
| DDX3X_HUMAN | DDX3X | physical | 26344197 | |
| DHX15_HUMAN | DHX15 | physical | 26344197 | |
| DHX16_HUMAN | DHX16 | physical | 26344197 | |
| DOHH_HUMAN | DOHH | physical | 26344197 | |
| IF4G1_HUMAN | EIF4G1 | physical | 26344197 | |
| IF4G3_HUMAN | EIF4G3 | physical | 26344197 | |
| ENOPH_HUMAN | ENOPH1 | physical | 26344197 | |
| MCM3_HUMAN | MCM3 | physical | 26344197 | |
| MCM5_HUMAN | MCM5 | physical | 26344197 | |
| NH2L1_HUMAN | NHP2L1 | physical | 26344197 | |
| NOC3L_HUMAN | NOC3L | physical | 26344197 | |
| NSUN2_HUMAN | NSUN2 | physical | 26344197 | |
| RPB4_HUMAN | POLR2D | physical | 26344197 | |
| RPB7_HUMAN | POLR2G | physical | 26344197 | |
| RBM8A_HUMAN | RBM8A | physical | 26344197 | |
| LA_HUMAN | SSB | physical | 26344197 | |
| ZO2_HUMAN | TJP2 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-131, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-610, AND MASSSPECTROMETRY. | |